COVID-19 Vaccines for Pregnant Moms May Protect Newborns
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.
COVID-19 Vaccines for Pregnant Moms May Protect Newborns
COVID-19 Vaccines for Pregnant Moms May Protect Newborns

A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.

A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.

immunology
Understanding Immune-Mediated Damage After Respiratory Infection
Understanding Immune-Mediated Damage After Respiratory Infection
The Scientist Creative Services Team in collaboration with 10x Genomics | Feb 17, 2021
Paul Thomas from St. Jude Children’s Research Hospital will discuss how he used single cell and spatial transcriptomics to discover the underlying mechanism of an inflammatory immune response in the lungs.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena | Feb 16, 2021
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
Catherine Offord | Jan 27, 2021
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
SARS-CoV-2 Isn’t Going Away, Experts Predict
SARS-CoV-2 Isn’t Going Away, Experts Predict
David Adam | Jan 25, 2021
As politicians try to schedule an end to the pandemic, scientists say the virus will stick around as an endemic disease similar to the common cold.
Moderna Developing Booster Shot for New Virus Variant B.1.351
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.